Clinical Trial Update: Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using duvelisib as maintenance therapy after autologous stem cell transplant in T-cell lymphoma; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Drugs mentioned

• Duvelisib (Copiktra) (duvelisib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: T-Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING